The CRISPR-SCD trial is the first clinical attempt to use a non-viral delivery approach to directly correct the sickle cell ...

A subset of patients with myeloproliferative neoplasms (MPNs) -- clonal disorders of hematopoietic stem cells that include ...

Senti Bio (SNTI)science reported positive initial clinical data from a Phase 1 clinical trial of SENTI-202, a potential ...

FELIX study results reveal obe-cel's potential in relapsed B-cell ALL, achieving 77% remission with low severe toxicity, ...

A 56-year-old man achieves remission from aggressive stage 4 non-Hodgkin's lymphoma after undergoing innovative CAR-T cell therapy at Medanta Hospital, overcoming prior treatment failures and serious ...

A 13-year-old male patient presented with a primary complaint of reduced vision in both eyes for the past 15 days at LV ...

A novel CAR T-cell therapy has benefitted patients with relapsed acute lymphoblastic leukemia, showing high response rates in ...

The 66th Annual Meeting & Exposition of the American Society of Hematology (ASH) will take place in San Diego, Calif. and online Dec. 7-10. Improving access to life-saving therapies for blood ...

While the holidays are a time many look forward to with joy and excitement, they can cause a range of emotions for others who ...

Researchers have identified that the SARS-CoV-2 spike protein accumulates in the brain's protective layers, potentially ...

The five-year-old is unable to go out in public due to her severely weakened immune system and suffers from heavy pains in ...

We’ve always had a very close relationship,” one twin said. “People always said we were like one coat of paint.” ...